Spencer B King

Summary

Affiliation: Piedmont Hospital
Country: USA

Publications

  1. ncbi request reprint Do elderly patients with non-ST-segment elevation acute coronary syndromes benefit from early invasive treatment?
    Spencer B King
    Emory University School of Medicine
    Nat Clin Pract Cardiovasc Med 3:188-9. 2006
  2. ncbi request reprint Applying drug-eluting stents in clinical practice
    Spencer B King
    Fuqua Heart Center at Piedmont Hospital, Atlanta, Georgia 30309, USA
    Am J Cardiol 100:25K-31K. 2007
  3. doi request reprint Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent
    Lakshmana K Pendyala
    Saint Joseph s Translational Research Institute, Atlanta, Georgia 30313, USA
    JACC Cardiovasc Interv 5:436-44. 2012
  4. doi request reprint High-density lipoprotein subclasses and their relationship to cardiovascular disease
    H Robert Superko
    Mercer University School of Pharmacy Sciences, Atlanta, GA, USA
    J Clin Lipidol 6:496-523. 2012
  5. doi request reprint Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model
    Takamitsu Nakamura
    Saint Joseph s Translational Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30313, USA
    JACC Cardiovasc Interv 4:247-55. 2011
  6. doi request reprint Ambulatory discharge after transradial coronary intervention: Preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study)
    Refat Jabara
    Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, Atlanta, GA 30342, USA
    Am Heart J 156:1141-6. 2008
  7. ncbi request reprint Comparison of the clinical characteristics of apical and non-apical variants of "broken heart" (takotsubo) syndrome in the United States
    Refat Jabara
    Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, 5673 Peachtree Dunwoody Road, Suite 675, Atlanta, GA 30342, USA
    J Invasive Cardiol 21:216-22. 2009
  8. doi request reprint Late angiographic stent thrombosis: the LAST straw for drug-eluting stents?
    Jack P Chen
    Department of Cardiology, Saint Joseph s Hospital of Atlanta, Atlanta, Georgia, USA
    Angiology 59:667-75. 2008
  9. doi request reprint Firefighters, heart disease, and aspects of insulin resistance: the FEMA Firefighter Heart Disease Prevention study
    H Robert Superko
    Saint Josephs Research Institute, Mercer University School of Pharmaceutical Sciences, Atlanta, Georgia, USA
    J Occup Environ Med 53:758-64. 2011
  10. doi request reprint Clinical and angiographic features of small vessel stenting in the drug-eluting stent era
    Refat Jabara
    Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30342, USA
    Clin Cardiol 32:E40-5. 2009

Detail Information

Publications43

  1. ncbi request reprint Do elderly patients with non-ST-segment elevation acute coronary syndromes benefit from early invasive treatment?
    Spencer B King
    Emory University School of Medicine
    Nat Clin Pract Cardiovasc Med 3:188-9. 2006
  2. ncbi request reprint Applying drug-eluting stents in clinical practice
    Spencer B King
    Fuqua Heart Center at Piedmont Hospital, Atlanta, Georgia 30309, USA
    Am J Cardiol 100:25K-31K. 2007
    ..Safety of the procedure must continue to be the first consideration, and technique must not be compromised to accommodate new technology...
  3. doi request reprint Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent
    Lakshmana K Pendyala
    Saint Joseph s Translational Research Institute, Atlanta, Georgia 30313, USA
    JACC Cardiovasc Interv 5:436-44. 2012
    ....
  4. doi request reprint High-density lipoprotein subclasses and their relationship to cardiovascular disease
    H Robert Superko
    Mercer University School of Pharmacy Sciences, Atlanta, GA, USA
    J Clin Lipidol 6:496-523. 2012
    ..To assess the clinical utility of measuring high-density lipoprotein (HDL) subfractions to assess coronary heart disease (CHD) risk...
  5. doi request reprint Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model
    Takamitsu Nakamura
    Saint Joseph s Translational Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30313, USA
    JACC Cardiovasc Interv 4:247-55. 2011
    ..The purpose of this study was to evaluate endothelial function after post-dilation of bare-metal stents with paclitaxel-coated balloons (PCB) or non-drug-coated balloons (non-DCB) in a porcine model...
  6. doi request reprint Ambulatory discharge after transradial coronary intervention: Preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study)
    Refat Jabara
    Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, Atlanta, GA 30342, USA
    Am Heart J 156:1141-6. 2008
    ..Although the safety and cost-effectiveness of same-day discharge after uncomplicated transradial percutaneous coronary intervention (TR-PCI) is well established in Europe and Asia, such data are not available for US patients...
  7. ncbi request reprint Comparison of the clinical characteristics of apical and non-apical variants of "broken heart" (takotsubo) syndrome in the United States
    Refat Jabara
    Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, 5673 Peachtree Dunwoody Road, Suite 675, Atlanta, GA 30342, USA
    J Invasive Cardiol 21:216-22. 2009
    ..The present study was designed to delineate and compare the clinical characteristics of patients with apical and non-apical takotsubo syndrome in a high-volume U.S. hospital...
  8. doi request reprint Late angiographic stent thrombosis: the LAST straw for drug-eluting stents?
    Jack P Chen
    Department of Cardiology, Saint Joseph s Hospital of Atlanta, Atlanta, Georgia, USA
    Angiology 59:667-75. 2008
    ..Moreover, when deployed for "on-label" indications, they provide significant restenosis advantage, with a slight late thrombotic risk but without overall increase in death or infarction...
  9. doi request reprint Firefighters, heart disease, and aspects of insulin resistance: the FEMA Firefighter Heart Disease Prevention study
    H Robert Superko
    Saint Josephs Research Institute, Mercer University School of Pharmaceutical Sciences, Atlanta, Georgia, USA
    J Occup Environ Med 53:758-64. 2011
    ..To determine the association of cardiovascular risk markers with noninvasive imaging of atherosclerosis in firefighters...
  10. doi request reprint Clinical and angiographic features of small vessel stenting in the drug-eluting stent era
    Refat Jabara
    Saint Joseph s Cardiovascular Research Institute, Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30342, USA
    Clin Cardiol 32:E40-5. 2009
    ....
  11. doi request reprint Revascularization for coronary artery disease: stents versus bypass surgery
    Spencer B King
    Saint Joseph s Heart and Vascular Institute, Atlanta, Georgia 30342, USA
    Annu Rev Med 61:199-213. 2010
    ..It is in this patient population where the debate over revascularization with stents versus surgery continues...
  12. doi request reprint Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress
    Lakshmana K Pendyala
    Saint Joseph s Translational Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia 30342, USA
    JACC Cardiovasc Interv 2:253-62. 2009
    ..production after overlapping paclitaxel-eluting stent (PES) implantation in a porcine model...
  13. ncbi request reprint Angioplasty is better than medical therapy for alleviating chronic angina pectoris
    Spencer B King
    Fuqua Heart Center, Piedmont Hospital, 95 Collier Road NW, Ste 2075, Atlanta, GA 30309, USA
    Arch Intern Med 165:2589-92, discussion 2592-3. 2005
  14. ncbi request reprint From balloon angioplasty to drug-eluting stents: revolution or evolution?
    Spencer B King
    Cardiology of Georgia, 95 Collier Road NW, Suite 2075, Atlanta, GA 30309 1749, USA
    Am Heart Hosp J 2:73-9. 2004
    ..As more data are accumulated, prudent selective use of drug-eluting stenting seems most appropriate...
  15. doi request reprint Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention
    Refat Jabara
    Saint Joseph s Cardiovascular Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia, USA
    Am J Cardiol 103:1657-62. 2009
    ..The wide variation in CIN and its lack of association with adverse outcomes underscore the need for a standardized, clinically relevant definition...
  16. ncbi request reprint Is surgery preferred for the diabetic with multivessel disease? Surgery is preferred for the diabetic with multivessel disease
    Spencer B King
    The Fuqua Heart Center, Atlanta, GA 30309, USA
    Circulation 112:1500-7; discussion 1514-5. 2005
  17. doi request reprint Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia
    H Robert Superko
    Saint Joseph s Translational Research Institute, Atlanta, GA, USA
    Am J Cardiol 103:387-92. 2009
    ..In conclusion, this investigation revealed that a combination of a fibric acid derivative and nicotinic acid offers greater improvement in detailed lipoprotein subclass distribution and apolipoprotein ratios than monotherapy...
  18. ncbi request reprint Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era
    Ziyad Ghazzal
    Andreas Gruentzig Cardiovascular Center of Emory University School of Medicine, Division of Cardiology, Atlanta, GA, USA
    Am Heart J 145:1006-12. 2003
    ..We evaluated the significance of creatine phosphokinase level (CPK) elevations in a large cohort of patients who had undergone an elective PCI before the IIb/IIIa receptor antagonist era...
  19. doi request reprint Commentary for "Comparison of drug eluting stents with bare metal stents in unselected patients with acute myocardial infarction"
    Spencer B King
    Catheter Cardiovasc Interv 71:E1-2. 2008
  20. ncbi request reprint Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (B
    V S Srinivas
    Department of Medicine, Division of Cardiovascular Medicine, Albert Einstein College of Medicine Montefiore Medical Center, Bronx, NY, USA
    Circulation 106:1627-33. 2002
    ..Patients having balloon angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI) and those within the Dynamic Registry meeting BARI eligibility criteria were studied...
  21. doi request reprint Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit
    Christopher P Cannon
    TIMI Study Group, Brigham and Women s Hospital, Boston, MA 02115, USA
    Crit Pathw Cardiol 7:43-81. 2008
    ..These materials are being made available online to help physicians, nurses, and hospitals implement the new guidelines and thus improve the quality of care and outcomes for patients with ACS...
  22. ncbi request reprint Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)
    Warren K Laskey
    University of Maryland School of Medicine, Baltimore, Maryland, USA
    Am J Cardiol 90:1062-7. 2002
    ..73, 95% CI 0.61 to 0.88; adjusted RR in patients with diabetes 1.20, 95% CI 0.88 to 1.65). Beta blockers at the time of hospital discharge were significantly associated with reduced mortality rates at 1 year in both groups...
  23. ncbi request reprint A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents
    Edward L Hannan
    School of Public Health, University at Albany, State University of New York, Albany, NY 12144 3456, USA
    Am Heart J 154:545-53. 2007
    ..There are only 2 approved devices: sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES). Only a few population-based studies have compared their patient outcomes...
  24. ncbi request reprint Restenosis: the mouse that roared
    Spencer B King
    Circulation 108:248-9. 2003
  25. ncbi request reprint ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and
    Spencer B King
    Circulation 116:98-124. 2007
  26. ncbi request reprint Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): prologue to COURAGE
    Spencer B King
    Circulation 115:1064-6. 2007
  27. ncbi request reprint Volume-outcome relationships for percutaneous coronary interventions in the stent era
    Edward L Hannan
    State University of New York, Albany, NY, USA
    Circulation 112:1171-9. 2005
    ..Most studies that are the basis of recommended volume thresholds for percutaneous coronary interventions (PCIs) predate the routine use of stent placement...
  28. ncbi request reprint Bare-metal stent outcomes in an unselected patient population
    A Yock
    Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California 94305 6019, USA
    Clin Cardiol 29:352-6. 2006
    ..Randomized trials have shown that drug-eluting stents (DES) substantially reduce in-stent restenosis compared with bare-metal stents (BMS)...
  29. ncbi request reprint ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and
    Spencer B King
    J Am Coll Cardiol 50:82-108. 2007
  30. ncbi request reprint A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease
    V S Srinivas
    Circulation 107:e88. 2003
  31. doi request reprint Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents
    Edward L Hannan
    School of Public Health, State University of New York, University at Albany, One University Place, Rensselaer, NY 12144 3456, USA
    Circulation 117:2071-8. 2008
    ..The purpose of the present study was to compare outcomes for patients who underwent stenting in the eras before and after the introduction of DES...
  32. ncbi request reprint Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial
    Xue Qiao Zhao
    Department of Medicine, Cardiology Division, University of Washington School of Medicine, Seattle, WA 98103, USA
    Med Sci Monit 9:CR48-54. 2003
    ..The natural history of atherosclerosis progression following revascularization procedures (PTCA or CABG) limits the long-term benefits of these procedures and requires continuation of risk management...
  33. ncbi request reprint Why have stents replaced balloons? Underwhelming evidence
    Spencer B King
    Ann Intern Med 138:842-3. 2003
  34. ncbi request reprint Dilate or defer? View of a skeptic
    Spencer B King
    J Am Coll Cardiol 42:1171-2. 2003
  35. ncbi request reprint Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial
    David R Holmes
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Circulation 106:1243-50. 2002
    ..No oral agent has shown a beneficial effect on restenosis or on associated major adverse cardiovascular events. In limited trials, the oral agent tranilast has been shown to decrease the frequency of angiographic restenosis after PCI...
  36. ncbi request reprint A risk score to predict in-hospital mortality for percutaneous coronary interventions
    Chuntao Wu
    University at Albany, State University of New York, Albany, New York, USA
    J Am Coll Cardiol 47:654-60. 2006
    ..Our purpose was to develop a risk score to predict in-hospital mortality for percutaneous coronary intervention (PCI) using a statewide population-based PCI registry...
  37. ncbi request reprint Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
    Gilles Montalescot
    Institut de Cardiologie, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    N Engl J Med 355:1006-17. 2006
    ..Several small studies have suggested that intravenous enoxaparin may be a safe and effective alternative. Our primary aim was to assess the safety of enoxaparin as compared with that of unfractionated heparin in elective PCI...
  38. ncbi request reprint Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era
    Edward L Hannan
    State University of New York, University at Albany, Rensselaer, NY 12144 3456, USA
    Circulation 113:2406-12. 2006
    ....
  39. ncbi request reprint Differences in utilization of drug-eluting stents by race and payer
    Edward L Hannan
    University at Albany, State University of New York, Albany, NY, USA
    Am J Cardiol 100:1192-8. 2007
    ..93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely...
  40. ncbi request reprint The editor's roundtable: chronic stable angina pectoris
    Vincent E Friedewald
    Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA
    Am J Cardiol 100:1635-43. 2007
  41. ncbi request reprint 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence an
    Spencer B King
    Circulation 117:261-95. 2008
  42. doi request reprint 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines
    Spencer B King
    J Am Coll Cardiol 51:172-209. 2008
  43. ncbi request reprint SCAI statement on drug-eluting stents: practice and health care delivery implications
    John McB Hodgson
    Heart and Vascular Center, MetroHealth Medical Center, Cleveland, Ohio 44109, USA
    Catheter Cardiovasc Interv 58:397-9. 2003